By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


ContraFect Corporation 

28 Wells Avenue, Third Floor

Yonkers  New York   10701  U.S.A.
Phone: 914-207-2300 Fax: n/a



Company News
ContraFect (CFRXU) Announces Fourth Quarter And Full Year 2014 Results 4/6/2015 10:27:07 AM
ContraFect (CFRXU) To Present At 27th Annual ROTH Conference 3/3/2015 9:59:48 AM
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/9/2015 2:25:16 PM
ContraFect Corporation (CFRXU) To Present at 17th Annual BIO CEO & Investor Conference 2/5/2015 12:39:04 PM
ContraFect Corporation (CFRXU) To Present Company Overview, Including Clinical Plan For CF-301, At The 7th Annual Biotech Showcase 1/7/2015 12:20:48 PM
ContraFect Corporation (CFRXU) Receives FDA Approval to Initiate Clinical Trials of CF-301 for MRSA Bloodstream Infections 12/22/2014 7:23:14 AM
ContraFect Corporation (CFRXU) To Present At The Oppenheimer 25th Annual Healthcare Conference 12/8/2014 2:42:47 PM
ContraFect Corporation (CFRXU) Submits Complete Response To IND Clinical Hold For CF-301 12/2/2014 12:10:05 PM
ContraFect Corporation (CFRXU) Announces Third Quarter 2014 Results 11/18/2014 5:00:15 PM
ContraFect Corporation (CFRXU) And China's IVDC Collaborate On Universal Flu Treatment 10/10/2014 12:22:00 PM